COMMUNIQUÉS West-GlobeNewswire

Board member Roland Norberg requests to resign from the Board
12/02/2025
Aino Health AB's board member Roland Norberg has today, 12 February 2025, requested to resign from the company's board. The reason for the resignation is that the company that nominated Roland Norberg, Norberg & [...]
Pedal for Progress with Jack Ride: Canadians Ride for Youth Mental Health
12/02/2025
Join tens of thousands of Jack.org supporters to raise hope and funds together CAPTION: Hundreds come together for Jack Ride to support programs equipping youth with vital mental health education TORONTO, Feb. 12, 2025 [...]
Pédalons pour la cause : la Jack Ride mobilise le pays pour la santé mentale des jeunes
12/02/2025
Rejoignez les milliers de Canadien.ne.s qui se mobilisent pour offrir espoir et soutien à la jeunesse LÉGENDE : Des centaines de participant.e.s qui unissent leurs efforts lors de la Jack Ride pour financer des [...]
ZymoChem Achieves Commercial-Scale Production of Key Biopolymer Ingredient For BAYSE BioSAP
12/02/2025
Biomanufacturing Leader Scales Up Technology to Drive Sustainability in Chemicals Industry SAN LEANDRO, Calif., Feb. 12, 2025 (GLOBE NEWSWIRE) -- ZymoChem , the biotech company creating sustainable materials for [...]
Adial Pharmaceuticals Awarded New U.S. Patent Covering Genotype-Specific Treatment of Opioid-Related Disorders
12/02/2025
New Patent expands patent estate covering Adial’s unique molecular genetic approach to diagnosing and potentially treating alcohol and drug dependence GLEN ALLEN, Va., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Adial [...]
New York Blood Center Enterprises Researchers Identify New Immune Response Mechanisms in Sickle Cell Disease
12/02/2025
NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- New York City Blood Center Enterprises (“NYBCe”) today announced that their researchers have uncovered a critical mechanism that could potentially transform treatment [...]
Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered Enzymes
12/02/2025
Rebranding Invizyne Technologies, Inc to eXoZymes Inc. Changing NASDAQ ticker from IZTC to EXOZ Introducing but not trademarking “exozymes” as a new scientific nomenclature Monrovia, California, Feb. 12, 2025 (GLOBE [...]
Bluejay Therapeutics Appoints Mary Cromwell as Senior Vice President and Head of Technical Operations
12/02/2025
REDWOOD CITY, Calif., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Bluejay Therapeutics , a clinical-stage biopharmaceutical company dedicated to developing potentially life-changing therapeutics for serious viral and liver [...]
MAPS Announces Search for New Executive Director as it Doubles Down on Advocacy and Movement Building
12/02/2025
MAPS’ next Executive Director will be a bold movement leader and visionary responsible for implementing MAPS' new strategic impact plan, ensuring programmatic excellence, advancing global expansion, and major donor [...]
Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025
12/02/2025
The Company will Host a Conference Call and Webcast on February 27, 2025, at 8:30 AM ET CORAL GABLES, Fla., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a [...]
Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025
11/02/2025
ALACHUA, Fla. and TAMPA, Fla., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that [...]
Supernus Pharmaceuticals to Host Conference Call and Webcast on February 25, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results
11/02/2025
ROCKVILLE, Md., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]
Precision Optics Schedules Second Quarter of Fiscal Year 2025 Conference Call for February 13, 2025
11/02/2025
GARDNER, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/ [...]
Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement
11/02/2025
WORCESTER, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO) today announced that it has received notice from The Nasdaq Stock Market LLC (“Nasdaq”) informing the [...]
RxSight, Inc. to Report Fourth Quarter Financial Results on February 25, 2025
11/02/2025
ALISO VIEJO, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced [...]
Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.
11/02/2025
-- Targeting Unmet Needs for Treating Solid Tumors-- REDWOOD CITY, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics, Inc., announced today that the target of their worldwide co-development collaboration [...]
Regeneron Announces Investor Conference Presentations
11/02/2025
TARRYTOWN, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) will webcast management participation as follows: TD Cowen 45 th Annual Health Care Conference at 11:50 a.m. ET on [...]
Ceribell to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025
11/02/2025
SUNNYVALE, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological [...]
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results
11/02/2025
SEATTLE, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive [...]

Pages